Gold Slipped on Vaccine News

Gold Slipped on Vaccine News

Gold slipped Wednesday on the latest positive COVID-19 vaccine news, but the anticipated economic impact of surging coronavirus cases is still giving the bullion support.

Pfizer announced on Wednesday final results from its vaccine trial showed a 95% success rate, so the drugmaker is set to apply for emergency U.S. authorization. In other pandemic news, the FDA approved the first in-home COVID test. The positive headlines are, however, overshadowed by the disease’s statistics. The U.S. has over 11 million infections and is set to pass the 250,000 death count today. Lockdowns are being imposed by states, cities and countries around the world.

Gold futures fell $2.70 Tuesday to settle at $1,885.10 an ounce on Comex, and the December contract dropped $1.10 in the first two days of the week. Gold is up more than $350 — or 24% — so far this year as investors have flocked to gold because of uncertainty from the coronavirus pandemic and the economy. It slipped 0.8% in October, its third consecutive monthly decline. Currently, the December contract is $1,875.80 an ounce, while the DG spot price is $1,880.10.

As gold has traded within a tight range, investors are turning their attention to the likelihood of government stimulus efforts to boost the economy. The presidents of the Federal Reserve’s New York. St. Louis, Dallas and Atlanta branches are set to speak on the economy on Wednesday.

U.S. retail sales figures for October rose less than expected, according to data released Tuesday. Pandemic-related lockdowns have sent millions of Americans into unemployment. Weekly initial jobless claims beat expectations last week, an indication that the labor market is improving, but the market will be watching for the next set on Thursday.

The virus known as COVID-19 has killed 1.34 million people worldwide and sickened 55.6 million. Almost 20% of the cases — and 19% of the deaths — are in the U.S. The country has more than 11.3 million cases, more than any other nation.

Investors are also watching Brexit negotiations underway this week in Europe as well as the presidential transition in the U.S.

Silver futures fell 1% Tuesday to settle at $24.56 an ounce on Comex. The December contract decreased 0.9% in the first two days of the week. The most active contract increased 0.6% in October. The December contract is down a bit to $24.455 an ounce, while the DG spot price is $24.48.

The World Platinum Investment Council projected a market deficit in 2020 and 2021 in a new report. The 2020 forecast shows the supply down 18%, while the demand down is only 5%, leading to a deficit of 1,202,000 ounces.

Spot palladium lost 0.4% Tuesday to $2,339.10 and was up 60 cents so far this week. It dropped 4.5% in October. Spot platinum advanced 0.9% Tuesday to $940.30 an ounce. It rose 4.6% in the first two days of the week and fell 6% in October. Currently, the DG spot price for platinum is up to 940.00 an ounce, while palladium is $2,350.20.


Disclaimer: This editorial has been prepared by Dillon Gage Metals for information and thought-provoking purposes only and does not purport to predict or forecast actual results. This editorial opinion is not to be construed as investment advice or as a recommendation regarding any particular security, commodity or course of action. Opinions expressed herein cannot be attributable to Dillon Gage. Reasonable people may disagree about the events discussed or opinions expressed herein. In the event any of the assumptions used herein do not come to fruition, results are likely to vary substantially. It is not a solicitation or advice to make any exchange in commodities, securities or other financial instruments. No part of this editorial may be reproduced in any manner, in whole or in part, without the prior written permission of Dillon Gage Metals. Dillon Gage Metals shall not have any liability for any damages of any kind whatsoever relating to this editorial. You should consult your advisers with respect to these areas. By posting this editorial, you acknowledge, understand and accept this disclaimer.